Showing 351-360 of 7612 results for "".
Cures All
https://practicaldermatology.com/topics/practice-management/cures-all/20771/What will the 21st Century Cures Act mean for dermatologists?Cash Flow: Beyond the Basics
https://practicaldermatology.com/topics/practice-management/cash-flow-beyond-the-basics/20846/How to use cash flow to your advantage and maximize business capital.Practice Consolidation: Wave of the Future?
https://practicaldermatology.com/topics/practice-management/practice-consolidation-wave-of-the-future/20911/Industry consolidation is yesterday's news. More and more small practices are joining larger groups.Heart of the Matter: Effects of Psoriasis Treatment on CV Risks
https://practicaldermatology.com/topics/psoriasis/heart-of-the-matter-effects-of-psoriasis-treatment-on-cv-risks/18747/By Jashin Wu, MD and Seemal R. Desai, MDThere's growing evidence that treatment of psoriasis reduces the risk of CV events, but it's not clear whether this potential benefit should influence treatment decisions. Patient screening and counseling remain important, Dr. Wu says.Online Reputation Management: Take Charge
https://practicaldermatology.com/topics/practice-management/online-reputation-management-take-charge/18601/Why is reputation management important for healthcare practices? Medical practices have an expectation to protect. Negative opinions can be shred quickly and widely, swaying patient opinion. A majority of individuals (88%) trust online reviews as much as personal recommendations, according to researUnderstanding the Cosmetic Patient
https://practicaldermatology.com/topics/practice-management/understanding-the-cosmetic-patient/18785/Laurie Hurt, Marketing Director for Cosmetic Surgery and Dermatology at CareCredit, shares insights on the research and buying habits of cosmetic surgery patients gleaned from The Path to Purchase Study.Managing Comorbidites of Psoriasis
https://practicaldermatology.com/topics/psoriasis/managing-comorbidites-of-psoriasis/18808/Ron Prussick, MD explains why it's important for dermatologists to discuss the risks of comorbidities such as cardiovascular events, fatty liver disease, depression, and more with patients with psoriasis. While it needs to be determined if the treatments used to treat the outside effects of psoriasiCellfina Cleared, Finacea Foam Approved
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-cellfina-cleared-finacea-foam-approved/18866/The FDA has cleared Cellfina (Ulthera Inc./Merz Aesthetics, Inc.) to treat cellulite, with results lasting for up to 2 years. Finacea Foam (azelaic acid, Bayer Dermatology) is approved for Rosacea, and Almirall invests in Suneva Medical, maker of Bellafill. Also in this edition, a look at the data oAdvocacy Groups and Physicians: The New Power Couple
https://practicaldermatology.com/topics/practice-management/advocacy-groups-and-physicians-the-new-power-couple/21191/Patient advocacy organizations partnering with dermatology physician-scientists offer an exciting new model for optimized patient care.Recently Passed Law Clears Way for New Sunscreen Ingredients
https://practicaldermatology.com/topics/skin-cancer-photoprotection/recently-passed-law-clears-way-for-new-sunscreen-ingredients/21232/By forcing the FDA to clear its backlog of sunscreen ingredients pending review, The Sunscreen Innovation Act is a major win for UV protection efforts.